(Q69043851)
Statements
[Clinical experience with single and multiple subcutaneous administration of LHRH analog Buserelin (Hoe 766) in prostatic carcinoma: endocrinological study of optimum subcutaneous doses] (English)
Niijima T
Isurugi K
Kawabe K
Kinoshita K
Asano M
Nakauchi K
Fujita K
Nishimura Y
Nitoh H